PerkinElmer Elects Frank Witney to Board of Directors
July 27 2016 - 4:15PM
Business Wire
PerkinElmer, Inc. (NYSE:PKI), a global leader focused on
improving the health and safety of people and the environment,
today announced that Frank Witney, Ph.D., has been elected to the
Company’s Board of Directors.
“I am delighted to welcome Frank to PerkinElmer’s Board, as he
brings deep market knowledge and over 30 years of leadership
experience across the life sciences, diagnostics and analytical
instruments industry,” said Robert Friel, Chairman and Chief
Executive Officer, PerkinElmer.
Most recently, Dr. Witney served as President and Chief
Executive Officer of Affymetrix, Inc. (now part of Thermo Fisher
Scientific), which specialized in microarray technology and
cellular analysis. Previously, Dr. Witney was President and Chief
Executive Officer of Dionex Corp., a market leading ion and high
performance liquid chromatography company. Prior to that, Dr.
Witney first joined Affymetrix when it acquired Panomics Inc., a
quantitative biology company, which he led as President and Chief
Executive Officer. Dr. Witney previously held the role of President
of PerkinElmer’s Drug Discovery Tools division following the
acquisition of Packard BioScience in 2001, where he served as
President and Chief Operating Officer. Dr. Witney also held several
positions at Bio-Rad Laboratories, leading that company's efforts
to enter the proteomic and bioassay technologies market.
Dr. Witney was a post-doctoral fellow at the National Institutes
of Health from 1980 to 1983 and holds a doctorate in molecular and
cell biology from Indiana University. He earned an undergraduate
degree in microbiology from the University of Illinois. He is
currently Chairman of the Board for Gyros Protein Technologies AB
and also holds Board positions for Cerus Corporation and Exagen
Diagnostics.
About PerkinElmer, Inc.PerkinElmer, Inc. is a global
leader focused on improving the health and safety of people and the
environment. The Company reported revenue of approximately $2.3
billion in 2015, has about 8,000 employees serving customers in
more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE,
or at www.perkinelmer.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160727006516/en/
PerkinElmer, Inc.Brian Willinsky,
+1-781-663-5728brian.willinsky@perkinelmer.com
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Aug 2024 to Sep 2024
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Sep 2023 to Sep 2024